Picard Medical Inc. shares surged nearly 43.9% in pre-market trading after the company reported second-quarter 2026 revenue significantly ahead of Wall Street expectations. Revenue for the quarter reached approximately $2.95 million, almost twice the analyst consensus estimate of around $1.55 million. The company reported a quarterly loss of $3.05 per share, compared with analysts' expectations for a loss of approximately $1.50 per share. The exchange accepted the company's compliance plan in late July, providing investors with additional clarity over its efforts to address outstanding listing requirements. The S&P 500 was down 0.1%, while the Nasdaq declined 0.6% and the Dow was broadly unchanged.
Picard Medical, Inc.Quarterly revenue beat forecasts, driving shares up nearly 44%
American Express Company